Introduction
The use of physiologic monitoring represents an important component in providing safe patient care. Despite of the impressive technological advances in the last decades, patient monitoring practices have not evolved to keep pace with the variety of physiological parameters that can be accessed and with the expansion in patient care areas that may be covered.
Need for an extended physiologic monitoring?
Traditionally, the primary application of monitoring restricts to high acuity settings within the hospital like intensive care units or operating suites. However, an increasing number of monitoring devices are being used to register data on less seriously ill patients within the hospital. And what happens to patients on the way to and after they leave the hospital is coming more and more into focus.
The availability of new unobtrusive sensors and powerful mobile devices such as smartphones and tablets offers the perspective to access physiologic data virtually anytime and anywhere. To use this potential, more sophisticated monitoring techniques are required. While in classical in-hospital settings recording conditions to a large extent can be controlled, future monitors require novel strategies to deal with issues like large time scales, context adaptation, detection of rare but critical events and managing uncertainty in the monitored signals.
Monitoring can improve quality of patient care since even slight changes in a patient's vital signs can be detected and treated. But excessive monitoring also may increase a patient's risk. Aside from primary negative effects due to invasive sensors and nuisance alarms, inadequate therapeutic intervention in response to excessive monitoring must be considered.
Conclusion
Novel monitoring techniques beyond classic in-hospital settings offer huge potential for improving quality of patient care but also challenge engineers, clinicians and health care providers. Together with technological aspects, ethic and legal issues have to be considered and clinical utility and patient benefit must be proven.
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